Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Nature Medicine
|
December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Lancet (London, England)
|
December 9, 2017
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Martin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, et al.
The Journal of Infectious Diseases
|
February 18, 2026
Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMO
Andrew P Platt, Viviane Callier, Alison Grazioli, et al.
Science Translational Medicine
|
December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M Lynch, Eli Boritz, Emily E Coates, et al.
The Lancet. Infectious Diseases
|
January 28, 2023
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
Kirsten E Lyke, Andrea A Berry, Kaitlin Mason, et al.
JCI Insight
|
February 24, 2025
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
Myra Happe, Rebecca M Lynch, Carl J Fichtenbaum, et al.
The New England Journal of Medicine
|
August 11, 2021
A Monoclonal Antibody for Malaria Prevention
Martin R Gaudinski, Nina M Berkowitz, Azza H Idris, et al.
The Lancet. HIV
|
September 2, 2019
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
Martin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, et al.
The New England Journal of Medicine
|
April 26, 2024
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria
Kassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
NPJ Vaccines
|
March 30, 2024
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
Myra Happe, Amelia R Hofstetter, Jing Wang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Nature Medicine
|
December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
Peng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.
Lancet (London, England)
|
December 9, 2017
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Martin R Gaudinski, Katherine V Houser, Kaitlyn M Morabito, et al.
The Journal of Infectious Diseases
|
February 18, 2026
Plasma biomarkers of immunothrombosis are independently associated with death in patients with COVID-19 on ECMO
Andrew P Platt, Viviane Callier, Alison Grazioli, et al.
Science Translational Medicine
|
December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M Lynch, Eli Boritz, Emily E Coates, et al.
The Lancet. Infectious Diseases
|
January 28, 2023
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial
Kirsten E Lyke, Andrea A Berry, Kaitlin Mason, et al.
JCI Insight
|
February 24, 2025
Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
Myra Happe, Rebecca M Lynch, Carl J Fichtenbaum, et al.
The New England Journal of Medicine
|
August 11, 2021
A Monoclonal Antibody for Malaria Prevention
Martin R Gaudinski, Nina M Berkowitz, Azza H Idris, et al.
The Lancet. HIV
|
September 2, 2019
Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial
Martin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, et al.
The New England Journal of Medicine
|
April 26, 2024
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria
Kassoum Kayentao, Aissata Ongoiba, Anne C Preston, et al.
NPJ Vaccines
|
March 30, 2024
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials
Myra Happe, Amelia R Hofstetter, Jing Wang, et al.
Page
of 8